Evolent Health
EVH
80 hedge funds and large institutions have $345M invested in Evolent Health in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 12 closing their positions.
154% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 13
98% more capital invested
Capital invested by funds: $174M → $345M (+$171M)
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
14% more funds holding
Funds holding: 70 → 80 (+10)
3.49% more ownership
Funds ownership: 38.69% → 42.18% (+3.5%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $10K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$3.49M |
| 2 |
CC
Casdin Capital
New York
|
+$3.29M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$3.16M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.84M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$4.74M |
| 2 |
PC
Pier Capital
Stamford,
Connecticut
|
-$3.47M |
| 3 |
Renaissance Technologies
New York
|
-$2.74M |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
-$1.34M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
-$1.27M |
EVH Hedge Fund Activity: Q2 2016 in Review
80 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2016, worth a combined $345M — up 98% from $174M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new EVH positions and 12 closed out — a net gain of 11 holders — while 33 added to existing stakes and 13 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $3.49M. The largest seller was Goldman Sachs, cutting an estimated $4.74M.
- 80 institutional investors held Evolent Health (EVH) as of Q2 2016, up from 70 in Q1 2016.
- Funds reported $345M of Evolent Health stock for Q2 2016, up 98% quarter-over-quarter.
- 23 funds opened new Evolent Health positions in Q2 2016 and 12 closed out, a net change of +11 holders.
- The largest Evolent Health buyer in Q2 2016 was Perceptive Advisors, an estimated $3.49M added.
- The largest Evolent Health seller in Q2 2016 was Goldman Sachs, an estimated $4.74M sold.
Based on aggregated 13F filings for Q2 2016.